PPARG and experimental autoimmune encephalomyelitis: For example, deletion of either PPARγ [43], PPARδ [44], or LXRα/β [35] results in aggravated disease progression in experimental autoimmune encephalomyelitis (EAE), the animal model of Multiple Sclerosis.